RecruitingACTRN12618000404224

Treatment of Recurrent and Advance Colorectal Cancer (TRACC): A prospective multi-site registry

Sponsor

Biogrid

Enrollment

3,000 participants

Start Date

Mar 24, 2009

Study Type

Observational

Conditions

Advanced Colorectal Cancer

Summary

The primary purpose of this study is to set up a registry of patients with recurrent and advanced colorectal cancer to evaluate patterns in the presentation, treatment and outcomes of the disease. It is for patients over the age of 18. Researchers will collect information relating to the presentation and characteristics of each participant's disease and information on treatments received and response to treatment by reviewing medical records. It is hoped that the findings from the registry will enhance our understanding of how treatments received and the timings of these treatments affect disease outcomes, and how these relate to the presentation and characteristics of colorectal cancers.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This is a patient registry — a large database of real-world information — for people with recurrent or advanced colorectal cancer (bowel cancer that has come back or spread to other parts of the body). Rather than testing a new treatment, the registry collects detailed information about patients' cancer characteristics, the treatments they receive, and how they respond over time. By pooling data from many patients across multiple hospitals, researchers hope to identify patterns in how different treatment approaches affect outcomes — including which treatments work best and at what timing. This kind of evidence is essential for improving future guidelines and care standards. You may be eligible if you are 18 or older and have been diagnosed with locally recurrent or metastatic colorectal cancer within the last 6 months. People who were first diagnosed with metastatic bowel cancer more than 6 months ago are not eligible to join the registry.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Registry of metastatic colorectal cancer (mCRC) patients across multiple sites in Australia. To evaluate the presentation, treatment, and outcomes of consective patients with recently diagnosed mCRC managed in routine care and to compare the characteristics and clinical outcomes in patients who do and who do not receive surgery or systemic treatment as part of their treatment regime.